Application 220837

Type
NDA
Sponsor
APOTEX

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EVDITRABECTEDINSOLUTION;INTRAVENOUS1MG/20ML (0.05MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85836ORIG 2026-05-05
85827ORIG 2026-05-04